Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

  title={Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder},
  author={Lisa M. Bendz and Ann C Scates},
  journal={Annals of Pharmacotherapy},
  pages={185 - 191}
OBJECTIVE To evaluate the efficacy and safety of melatonin for the treatment of insomnia in pediatric patients with attention-deficit/hyperactivity disorder (ADHD). DATA SOURCES Literature was accessed through MEDLINE (1948-August 2009), EMBASE (1950-August 2009), and Scopus (1960-August 2009) using the terms melatonin, attention-deficit/hyperactivity disorder (ADHD), pediatric, insomnia, sleep disorder, and sleep. In addition, reference citations from publications identified were reviewed for… 

Tables from this paper

Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis

Melatonin appeared safe and effective in improving sleep in the studied children, and the overall quality of the evidence was limited due to heterogeneity and inconsistency.

To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.

There is a relative paucity of evidence for the pharmacological treatment of ADHD-related sleep disorders; therefore, further research should be conducted to replicate these findings and obtain reliable results.

Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trial

This study will provide the first prospectively planned head-to-head comparison of RCT data with pooled data from a series of N-of-1 trials, and may be a powerful tool to produce high quality clinical trial evidence.

A systematic review of the effectiveness of sleep hygiene in children with ADHD

There is growing evidence to support the use of sleep hygiene interventions to improve sleep quality in children with ADHD and sleep disturbance, however, well-conducted clinical trials are required to strengthen the evidence.

Sleep Problems as Predictors in Attention-Deficit Hyperactivity Disorder: Causal Mechanisms, Consequences and Treatment

  • Y. UmSeung-Chul HongJong-Hyun Jeong
  • Psychology
    Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
  • 2017
This work has concluded that genetic-phenotypic differences across individuals regarding the aforementioned sleep problems have been elucidated along with the possible use of these characteristics for early prediction of ADHD.

Review of Melatonin Supplementation for Sleep Disorders in Pediatric Special Populations

The benefit of exogenous melatonin supplementation outweighs the risks of adverse events and therefore the author would recommend its use in aiding patients in improving their sleep.

Clinical Uses of Melatonin in Pediatrics

Melatonin is beneficial not only in the treatment of dyssomnias, especially delayed sleep phase syndrome, but also on sleep disorders present in children with attention-deficit hyperactivity, autism spectrum disorders, and in all sleep disturbances associated with mental, neurologic, or other medical disorders.

Melatonin effects on sleep disorders in children with attention deficit hyperactivity disorder

By improving children's sleep, not only the daily functions improve, but also the symptoms of attention deficit hyperactivity disorder maybe become better and the administration of psychostimulants, which have recognized side effects should be avoided.

Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management

This review aimed to provide the most updated information, preferably based on meta-analyses, systemic review, and randomized controlled trials published in the latest 3 years, in order to be clinically useful for practitioners and clinicians.



Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.

Combined sleep hygiene and melatonin was a safe and effective treatment for initial insomnia in children with ADHD taking stimulant medication.

Long‐term follow‐up of melatonin treatment in children with ADHD and chronic sleep onset insomnia

It is concluded that melatonin remains an effective therapy on the long term for the treatment of CSOI in children with ADHD and has no safety concerns regarding serious adverse events or treatment related co‐morbidity.

Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.

Melatonin advanced circadian rhythms of sleep-wake and endogenous melatonin and enhanced total time asleep in children with ADHD and chronic sleep onset insomnia; however, no effect was found on problem behavior, cognitive performance, or quality of life.

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study

A dose of 3 mg melatonine reduces the time of falling asleep significantly in attention deficit/hyperactivity disorder (ADHD) subjects on methylphenidate treatment. Insomnia occurs in up to 54% in

Pharmacological management of treatment-induced insomnia in ADHD.

ADHD AND INSOMNIA VIGNETTE A 7-year-old girl with attention-deficit/hyperactivity disorder (ADHD), combined subtype, and oppositional defiant disorder presents with a complaint of marked insomnia.

Clinical trials of controlled‐release melatonin in children with sleep–wake cycle disorders

The studies showed that the FR melatonin was most effective when there was only delayed sleep onset, but CR formulations were more useful for sleep maintenance, and children appeared to require higher doses than adults.

Melatonin for Chronic Sleep Onset Insomnia in Children: A Randomized Placebo-Controlled Trial

The results show that melatonin, 5 mg at 6 PM, was relatively safe to take in the short term and significantly more effective than placebo in advancing sleep onset and dim light melatonin onset and increasing sleep duration in elementary school children with chronic sleep onset insomnia.

Pharmacologic Management of Insomnia in Children and Adolescents: Consensus Statement

A consensus statement on the current status and future role for pharmacologic management of insomnia in children and adolescents was developed and priority should be given to insomnia studies in children with attention-deficit/hyperactivity disorder and those with pervasive developmental disorders/autism spectrum disorder.

The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary.

  • J. OwensDebra L. Babcock S. Sheldon
  • Medicine, Psychology
    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
  • 2005
Use of medications for pediatric insomnia should be diagnostically driven, and should be implemented in conjunction with empirically-based behavioral treatment strategies and adequate sleep hygiene and additional research is critically needed to provide an evidence-based approach.